|
1
|
Theise ND, Chen CJ and Kew MC: Liver
cancerWorld Cancer Report 2014. Stewart B and Wild C: International
Agency for Research on Cancer; Lyon: pp. 577–593. 2014
|
|
2
|
Hsu YS, Chien RN, Yeh CT, et al: Long-term
outcome after spontaneous HBeAg seroconversion in patients with
chronic hepatitis B. Hepatology. 35:1522–1527. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim TM, Yim SH, Shin SH, et al: Clinical
implication of recurrent copy number alterations in hepatocellular
carcinoma and putative oncogenes in recurrent gains on 1q. Int J
Cancer. 123:2808–2815. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patil MA, Gütgemann I, Zhang J, et al:
Array-based comparative genomic hybridization reveals recurrent
chromosomal aberrations and Jab1 as a potential target for 8q gain
in hepatocellular carcinoma. Carcinogenesis. 26:2050–2057. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Midorikawa Y, Tang W and Sugiyama Y:
High-resolution mapping of copy number aberrations and
identification of target genes in hepatocellular carcinoma. Biosci
Trends. 1:26–32. 2007.PubMed/NCBI
|
|
6
|
Guo X, Yanna, Ma X, et al: A meta-analysis
of array-CGH studies implicates antiviral immunity pathways in the
development of hepatocellular carcinoma. PLoS One. 6:e284042011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han ZG: Recent progress in genomic
research of liver cancer. Sci China C Life Sci. 52:24–30. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
International Consensus Group for
Hepatocellular Neoplasia: Pathologic diagnosis of early
hepatocellular carcinoma: A report of the international consensus
group for hepatocellular neoplasia. Hepatology. 49:658–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
International Working Party: Terminology
of nodular hepatocellular lesions. Hepatology. 22:983–993. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Di Tommaso L, Sangiovanni A, Borzio M, et
al: Advanced precancerous lesions in the liver. Best Pract Res Clin
Gastroenterol. 27:269–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sobin LH and Wittekind CH: TNM
Classification of Malignant Tumours. 6th. Wiley; New York, NY: pp.
81–83. 2002
|
|
12
|
Theise ND, Curado MP, Franceschi S, et al:
Hepatocellular carcinomaWHO Classification of Tumors of the
Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise ND:
International Agency for Research on Cancer; Lyon: pp. 205–216.
2010
|
|
13
|
Huang J, Grotzer MA, Watanabe T, et al:
Mutations in the Nijmegen breakage syndrome gene in
medulloblastomas. Clin Cancer Res. 14:4053–4058. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang J, Pang J, Watanabe T, Ng HK and
Ohgaki H: Whole genome amplification for array comparative genomic
hybridization using DNA extracted from formalin-fixed,
paraffin-embedded histological sections. J Mol Diagn. 11:109–116.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun FY, Wan DF, Qing WX, et al:
Determination of gene deletion in tumor tissue by semi-quantitative
polymerase chain reaction. Tumor. 20:135–137. 2000.(In
Chinese).
|
|
16
|
Tomlinson IP, Lambros MB and Roylance RR:
Loss of heterozygosity analysis: Practically and conceptually
flawed? Genes Chromosomes Cancer. 34:349–353. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou HL, Gong L, Zhang W, Du YX, Zhang JY
and Feng YM: Loss of heterozygosity on chromosomes 8 and 16 in
primary hepatocellular carcinoma. Xian Dai Zhong Liu Yi Xue.
20:1134–1138. 2012.(In Chinese).
|
|
18
|
Lau SH and Guan XY: Cytogenetic and
molecular genetic alterations in hepatocellular carcinoma. Acta
Pharmacol Sin. 26:659–665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niketeghad F, Decker HJ, Caselmann WH, et
al: Frequent genomic imbalances suggest commonly altered tumour
genes in human hepatocarcinogenesis. Br J Cancer. 85:697–704. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rashid A, Wang JS, Qian GS, Lu BX,
Hamilton SR and Groopman JD: Genetic alterations in hepatocellular
carcinomas: association between loss of chromosome 4q and p53 gene
mutations. Br J Cancer. 80:59–66. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zondervan PE, Wink J, Alers JC, et al:
Molecular cytogenetic evaluation of virus-associated and non-viral
hepatocellular carcinoma: analysis of 26 carcinomas and 12
concurrent dysplasias. J Pathol. 192:207–215. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Laurent-Puig P, Legoix P, Bluteau O, et
al: Genetic alterations associated with hepatocellular carcinomas
define distinct pathways of hepatocarcinogenesis. Gastroenterology.
120:1763–1773. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong L, Li YH, Su Q, Chu X and Zhang W:
Clonality of nodular lesions in liver cirrhosis and chromosomal
abnormalities in monoclonal nodules of altered hepatocytes.
Histopathology. 56:589–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kakar S, Chen X, Ho C, et al: Chromosomal
abnormalities determined by comparative genomic hybridization are
helpful in the diagnosis of atypical hepatocellular neoplasms.
Histopathology. 55:197–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang F, Zhou C, Ling Y, et al: Allelic
analysis on chromosome 5 in sporadic colorectal cancer patients.
Zhonghua Zhong Liu Za Zhi. 24:458–460. 2002.(In Chinese).
PubMed/NCBI
|
|
26
|
Ding SF, Habib NA, Dooley J, et al: Loss
of constitutional heterozygosity on chromosome 5q in hepatocellular
carcinoma without cirrhosis. Br J Cancer. 64:1083–1087. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Johannsdottir HK, Jonsson G,
Johannesdottir G, et al: Chromosome 5 imbalance mapping in breast
tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast
tumors. Int J Cancer. 119:1052–1060. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang XS, Xiao L, Li X, et al: Two
neighboring microdeletions of 5q13.2 in a child with
oculo-auriculo-vertebral spectrum. Eur J Med Genet. 53:153–158.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen CP, Lin CJ, Chen CY, et al: Maternal
transmission of interstitial microdeletion in 5q13.2 detected
during prenatal diagnosis of coarctation of the aorta. Taiwan J
Obstet Gynecol. 52:303–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Markaverich BM, Shoulars K and Rodriquez
MA: Luteolin regulation of estrogen signaling and cell cycle
pathway genes in MCF-7 human breast cancer cells. Int J Biomed Sci.
7:101–111. 2011.PubMed/NCBI
|
|
31
|
Du D, Xu F, Yu L, Zhang C, Lu X, Yuan H,
et al: The tight junction protein, occludin, regulates the
directional migration of epithelial cells. Dev Cell. 18:52–63.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kahng YS, Lee YS, Kim BK, Park WS, Lee JY
and Kang CS: Loss of heterozygosity of chromosome 8p and 11p in the
dysplastic nodule and hepatocellular carcinoma. J Gastroenterol
Hepatol. 18:430–436. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chan KL, Lee JM, Guan XY, Fan ST and Ng
IO: High-density allelotyping of chromosome 8p in hepatocellular
carcinoma and clinicopathologic correlation. Cancer. 94:3179–3185.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pineau P, Nagai H, Prigent S, et al:
Identification of three distinct regions of allelic deletions on
the short arm of chromosome 8 in hepatocellular carcinoma.
Oncogene. 18:3127–3134. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu T, Hano H, Meng C, et al: Frequent loss
of heterozygosity in two distinct regions, 8p23.1 and 8p22, in
hepatocellular carcinoma. World J Gastroenterol. 13:1090–1097.
2007. View Article : Google Scholar : PubMed/NCBI
|
